Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.
Huang
Haihui
H
Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Weintraub
Andrej
A
Fang
Hong
H
Nord
Carl Erik
CE
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001372:Aza Compounds / Q000494:pharmacology*; D016360:Clostridioides difficile / Q000145:classification / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D017714:Community-Acquired Infections / Q000382:microbiology*; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology*; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology; D006801:Humans; D000077266:Moxifloxacin; D011804:Quinolines / Q000494:pharmacology*; D021521:Ribotyping; D013548:Sweden
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin